Global Vaccines Administered Orally Market Research Report 2022

Global Vaccines Administered Orally Market Research Report 2022

Table of Contents
1 Vaccines Administered Orally Market Overview
1.1 Product Overview and Scope of Vaccines Administered Orally
1.2 Vaccines Administered Orally Segment by Type
1.2.1 Global Vaccines Administered Orally Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Human
1.2.3 Animal
1.3 Vaccines Administered Orally Segment by Application
1.3.1 Global Vaccines Administered Orally Sales Comparison by Application: (2022-2028)
1.3.2 Public
1.3.3 Private
1.4 Global Vaccines Administered Orally Market Size Estimates and Forecasts
1.4.1 Global Vaccines Administered Orally Revenue 2017-2028
1.4.2 Global Vaccines Administered Orally Sales 2017-2028
1.4.3 Vaccines Administered Orally Market Size by Region: 2017 Versus 2021 Versus 2028
2 Vaccines Administered Orally Market Competition by Manufacturers
2.1 Global Vaccines Administered Orally Sales Market Share by Manufacturers (2017-2022)
2.2 Global Vaccines Administered Orally Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Vaccines Administered Orally Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Vaccines Administered Orally Manufacturing Sites, Area Served, Product Type
2.5 Vaccines Administered Orally Market Competitive Situation and Trends
2.5.1 Vaccines Administered Orally Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vaccines Administered Orally Players Market Share by Revenue
2.5.3 Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccines Administered Orally Retrospective Market Scenario by Region
3.1 Global Vaccines Administered Orally Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Vaccines Administered Orally Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Vaccines Administered Orally Market Facts & Figures by Country
3.3.1 North America Vaccines Administered Orally Sales by Country
3.3.2 North America Vaccines Administered Orally Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Vaccines Administered Orally Market Facts & Figures by Country
3.4.1 Europe Vaccines Administered Orally Sales by Country
3.4.2 Europe Vaccines Administered Orally Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccines Administered Orally Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccines Administered Orally Sales by Region
3.5.2 Asia Pacific Vaccines Administered Orally Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Vaccines Administered Orally Market Facts & Figures by Country
3.6.1 Latin America Vaccines Administered Orally Sales by Country
3.6.2 Latin America Vaccines Administered Orally Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Vaccines Administered Orally Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccines Administered Orally Sales by Country
3.7.2 Middle East and Africa Vaccines Administered Orally Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Vaccines Administered Orally Historic Market Analysis by Type
4.1 Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)
4.2 Global Vaccines Administered Orally Revenue Market Share by Type (2017-2022)
4.3 Global Vaccines Administered Orally Price by Type (2017-2022)
5 Global Vaccines Administered Orally Historic Market Analysis by Application
5.1 Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)
5.2 Global Vaccines Administered Orally Revenue Market Share by Application (2017-2022)
5.3 Global Vaccines Administered Orally Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Vaccines Administered Orally Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.2.4 GSK Vaccines Administered Orally Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Vaccines Administered Orally Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lanzhou Institute Vaccines Administered Orally Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Serum Institute Vaccines Administered Orally Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Valneva Vaccines Administered Orally Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Shanghai United Cell Vaccines Administered Orally Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bibcol Vaccines Administered Orally Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Corporation Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.9.4 PaxVax Vaccines Administered Orally Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Vabiotech Vaccines Administered Orally Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Vaccines Administered Orally Description and Business Overview
6.11.3 Tiantan Biological Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Tiantan Biological Vaccines Administered Orally Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Vaccines Administered Orally Description and Business Overview
6.12.3 EuBiologics Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.12.4 EuBiologics Vaccines Administered Orally Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Vaccines Administered Orally Description and Business Overview
6.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Panacea Biotec Ltd Vaccines Administered Orally Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Vaccines Administered Orally Description and Business Overview
6.14.3 Bio-Med Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Bio-Med Vaccines Administered Orally Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Vaccines Administered Orally Manufacturing Cost Analysis
7.1 Vaccines Administered Orally Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccines Administered Orally
7.4 Vaccines Administered Orally Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccines Administered Orally Distributors List
8.3 Vaccines Administered Orally Customers
9 Vaccines Administered Orally Market Dynamics
9.1 Vaccines Administered Orally Industry Trends
9.2 Vaccines Administered Orally Market Drivers
9.3 Vaccines Administered Orally Market Challenges
9.4 Vaccines Administered Orally Market Restraints
10 Global Market Forecast
10.1 Vaccines Administered Orally Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccines Administered Orally by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Vaccines Administered Orally by Type (2023-2028)
10.2 Vaccines Administered Orally Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccines Administered Orally by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Vaccines Administered Orally by Application (2023-2028)
10.3 Vaccines Administered Orally Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccines Administered Orally by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Vaccines Administered Orally by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Vaccines Administered Orally Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Vaccines Administered Orally Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Vaccines Administered Orally Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Vaccines Administered Orally Market Competitive Situation by Manufacturers in 2021
Table 5. Global Vaccines Administered Orally Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Vaccines Administered Orally Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Vaccines Administered Orally Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Vaccines Administered Orally Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Vaccines Administered Orally Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Vaccines Administered Orally Manufacturing Sites and Area Served
Table 11. Manufacturers Vaccines Administered Orally Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vaccines Administered Orally by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines Administered Orally as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
Table 16. Global Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Table 17. Global Vaccines Administered Orally Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Table 19. North America Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 20. North America Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 21. North America Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 23. Europe Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 24. Europe Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 25. Europe Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Vaccines Administered Orally Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Vaccines Administered Orally Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Table 31. Latin America Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 33. Latin America Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Vaccines Administered Orally Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Vaccines Administered Orally Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Vaccines Administered Orally Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Vaccines Administered Orally Revenue Market Share by Country (2017-2022)
Table 39. Global Vaccines Administered Orally Sales by Type (2017-2022) & (K Units)
Table 40. Global Vaccines Administered Orally Sales Market Share by Type (2017-2022)
Table 41. Global Vaccines Administered Orally Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Vaccines Administered Orally Revenue Share by Type (2017-2022)
Table 43. Global Vaccines Administered Orally Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Vaccines Administered Orally Sales (K Units) by Application (2017-2022)
Table 45. Global Vaccines Administered Orally Sales Market Share by Application (2017-2022)
Table 46. Global Vaccines Administered Orally Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Vaccines Administered Orally Revenue Share by Application (2017-2022)
Table 48. Global Vaccines Administered Orally Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck Corporation Information
Table 50. Merck Description and Business Overview
Table 51. Merck Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck Vaccines Administered Orally Product
Table 53. Merck Recent Developments/Updates
Table 54. GSK Corporation Information
Table 55. GSK Description and Business Overview
Table 56. GSK Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. GSK Vaccines Administered Orally Product
Table 58. GSK Recent Developments/Updates
Table 59. Sanofi Corporation Information
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Sanofi Vaccines Administered Orally Product
Table 63. Sanofi Recent Developments/Updates
Table 64. Lanzhou Institute Corporation Information
Table 65. Lanzhou Institute Description and Business Overview
Table 66. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Lanzhou Institute Vaccines Administered Orally Product
Table 68. Lanzhou Institute Recent Developments/Updates
Table 69. Serum Institute Corporation Information
Table 70. Serum Institute Description and Business Overview
Table 71. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Serum Institute Vaccines Administered Orally Product
Table 73. Serum Institute Recent Developments/Updates
Table 74. Valneva Corporation Information
Table 75. Valneva Description and Business Overview
Table 76. Valneva Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Valneva Vaccines Administered Orally Product
Table 78. Valneva Recent Developments/Updates
Table 79. Shanghai United Cell Corporation Information
Table 80. Shanghai United Cell Description and Business Overview
Table 81. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Shanghai United Cell Vaccines Administered Orally Product
Table 83. Shanghai United Cell Recent Developments/Updates
Table 84. Bibcol Corporation Information
Table 85. Bibcol Description and Business Overview
Table 86. Bibcol Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Bibcol Vaccines Administered Orally Product
Table 88. Bibcol Recent Developments/Updates
Table 89. PaxVax Corporation Information
Table 90. PaxVax Description and Business Overview
Table 91. PaxVax Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. PaxVax Vaccines Administered Orally Product
Table 93. PaxVax Recent Developments/Updates
Table 94. Vabiotech Corporation Information
Table 95. Vabiotech Description and Business Overview
Table 96. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Vabiotech Vaccines Administered Orally Product
Table 98. Vabiotech Recent Developments/Updates
Table 99. Tiantan Biological Corporation Information
Table 100. Tiantan Biological Description and Business Overview
Table 101. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Tiantan Biological Vaccines Administered Orally Product
Table 103. Tiantan Biological Recent Developments/Updates
Table 104. EuBiologics Corporation Information
Table 105. EuBiologics Description and Business Overview
Table 106. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. EuBiologics Vaccines Administered Orally Product
Table 108. EuBiologics Recent Developments/Updates
Table 109. Panacea Biotec Ltd Corporation Information
Table 110. Panacea Biotec Ltd Description and Business Overview
Table 111. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Panacea Biotec Ltd Vaccines Administered Orally Product
Table 113. Panacea Biotec Ltd Recent Developments/Updates
Table 114. Bio-Med Corporation Information
Table 115. Bio-Med Description and Business Overview
Table 116. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Bio-Med Vaccines Administered Orally Product
Table 118. Bio-Med Recent Developments/Updates
Table 119. Halfkin Bio-Pharmaceuticals Corporation Information
Table 120. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 121. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product
Table 123. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Vaccines Administered Orally Distributors List
Table 127. Vaccines Administered Orally Customers List
Table 128. Vaccines Administered Orally Market Trends
Table 129. Vaccines Administered Orally Market Drivers
Table 130. Vaccines Administered Orally Market Challenges
Table 131. Vaccines Administered Orally Market Restraints
Table 132. Global Vaccines Administered Orally Sales Forecast by Type (2023-2028) & (K Units)
Table 133. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Vaccines Administered Orally Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Vaccines Administered Orally Sales Forecast by Application (2023-2028) & (K Units)
Table 137. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Vaccines Administered Orally Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Vaccines Administered Orally Sales Forecast by Region (2023-2028) & (K Units)
Table 141. Global Vaccines Administered Orally Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Vaccines Administered Orally Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccines Administered Orally
Figure 2. Global Vaccines Administered Orally Market Share by Type in 2021 & 2028
Figure 3. Human Product Picture
Figure 4. Animal Product Picture
Figure 5. Global Vaccines Administered Orally Market Share by Application in 2021 & 2028
Figure 6. Public
Figure 7. Private
Figure 8. Global Vaccines Administered Orally Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Vaccines Administered Orally Market Size (2017-2028) & (US$ Million)
Figure 10. Global Vaccines Administered Orally Sales (2017-2028) & (K Units)
Figure 11. Vaccines Administered Orally Sales Share by Manufacturers in 2021
Figure 12. Global Vaccines Administered Orally Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Vaccines Administered Orally Players: Market Share by Revenue in 2021
Figure 14. Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Vaccines Administered Orally Sales Market Share by Region (2017-2022)
Figure 16. Global Vaccines Administered Orally Sales Market Share by Region in 2021
Figure 17. Global Vaccines Administered Orally Revenue Market Share by Region (2017-2022)
Figure 18. Global Vaccines Administered Orally Revenue Market Share by Region in 2021
Figure 19. United States Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE Vaccines Administered Orally Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of Vaccines Administered Orally by Type (2017-2022)
Figure 42. Manufacturing Cost Structure of Vaccines Administered Orally
Figure 43. Manufacturing Process Analysis of Vaccines Administered Orally
Figure 44. Vaccines Administered Orally Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs